DrugPatentWatch Database Preview

Cppi Cv Company Profile

« Back to Dashboard

What is the competitive landscape for CPPI CV, and what generic alternatives to CPPI CV drugs are available?

CPPI CV has one approved drug.

There are three US patents protecting CPPI CV drugs.

There are sixty-eight patent family members on CPPI CV drugs in thirty-nine countries and twenty-one supplementary protection certificates in ten countries.

Summary for Cppi Cv

International Patents:	68
US Patents:	3
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Cppi Cv

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-004	Mar 31, 2009		RX	Yes	No	7,211,600
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-001	Jan 26, 2006		RX	Yes	No	6,573,293		Y	Y
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-004	Mar 31, 2009		RX	Yes	No	6,573,293		Y	Y
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-003	Jan 26, 2006		RX	Yes	Yes	7,211,600
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-002	Jan 26, 2006		RX	Yes	No	7,125,905		Y	Y
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-001	Jan 26, 2006		RX	Yes	No
Cppi Cv	SUTENT	sunitinib malate	CAPSULE;ORAL	021938-002	Jan 26, 2006		RX	Yes	No

Paragraph IV (Patent) Challenges for CPPI CV drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	12.5 mg, 25 mg, 37.5 mg and 50 mg		2010-01-26

Non-Orange Book US Patents for Cppi Cv

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,572,924	Pyrrole substituted 2-indolinone protein kinase inhibitors

International Patents for Cppi Cv Drugs

Country	Document Number	Estimated Expiration
New Zealand	519697
Colombia	5280092
Denmark	1255536
Australia	784266
Brazil	0108394
Bulgaria	65764
Japan	5004392

Supplementary Protection Certificates for Cppi Cv Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2010002	Lithuania		PRODUCT NAME: TOCERANIBUM; REGISTRATION NO/DATE: EU/2/09/100/001, 2009 09 23 EU/2/09/100/002, 2009 09 23 EU/2/09/100/003 20090923
C003/2010	Ireland		SPC003/2010: 20100702, EXPIRES: 20240922
2010000004	Germany		PRODUCT NAME: TOCERANIB UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/2/09/100/001-003 20090923
2008002,C1255752	Lithuania		PRODUCT NAME: SUNITINIBUM; REGISTRATION NO/DATE: EU/1/06/347/001, EU/1/06/347/002, EU/1/06/347/003 20060719
2008002	Lithuania		PRODUCT NAME: SUNITINIBUM; REG. NO/DATE: EU/1/06/347/001-003 20070808
657	Luxembourg		91657, EXPIRES: 20240923
0332	Netherlands

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cppi Cv